Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ichthammol glycerin
- Development stage
- Unknown
- Lead developer
- Medismith Pharma Lab
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
**Ichthammol glycerin** is a topical dermatological formulation containing ichthammol, typically at 10% w/w, in a glycerol-based vehicle. Ichthammol has a mild local bacteriostatic action, while glycerol acts as a humectant and emollient that softens and moisturizes skin. The BPC preparation is a viscous black topical liquid used for chronic eczema and is applied externally to intact skin. ([drugs.com](https://www.drugs.com/uk/ichthammol-glycerin-b-p-c-leaflet.html))
- Other names
- Ichthammol Glycerin BPC
Beyond the preview
Go deeper on ichthammol glycerin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ichthammol glycerin.